Terms: = Leukemia AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Diagnosis
4 results:
1. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
[TBL] [Abstract] [Full Text] [Related]
2. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract] [Full Text] [Related]
3. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract] [Full Text] [Related]
4. Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea.
Bruchova H; Borovanova T; Klamova H; Brdicka R
Leuk Lymphoma; 2002 Jun; 43(6):1289-95. PubMed ID: 12152998
[TBL] [Abstract] [Full Text] [Related]
